Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · IEX Real-Time Price · USD
17.33
+0.14 (0.81%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Tectonic Therapeutic Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2016
Selling, General & Admin
23.3423.9733.2535.7332.9920.84
Upgrade
Research & Development
31.0547.772.1983.1187.2454.97
Upgrade
Other Operating Expenses
-81.86-81.860000
Upgrade
Operating Expenses
-27.47-10.19105.43118.84120.2375.81
Upgrade
Operating Income
27.4710.19-105.43-118.84-120.23-75.81
Upgrade
Interest Expense / Income
-2.17-2.420.30.220.720
Upgrade
Other Expense / Income
-1.040.080.160.06-1.24-2.84
Upgrade
Pretax Income
30.6812.53-105.89-119.13-119.71-72.97
Upgrade
Income Tax
0.380.380000
Upgrade
Net Income
30.3112.16-105.89-119.13-119.71-72.97
Upgrade
Shares Outstanding (Basic)
444432
Upgrade
Shares Outstanding (Diluted)
444432
Upgrade
Shares Change
1.71%1.90%2.07%18.36%31.98%104.18%
Upgrade
EPS (Basic)
8.403.24-29.04-33.36-39.72-31.92
Upgrade
EPS (Diluted)
8.283.24-29.04-33.36-39.72-31.92
Upgrade
Free Cash Flow
-49.13-61.85-97.48-100.49-99.98-69.25
Upgrade
Free Cash Flow Per Share
-13.16-16.74-26.74-28.14-33.14-30.29
Upgrade
Effective Tax Rate
1.23%3.01%----
Upgrade
EBITDA
30.4412.64-101.43-117.5-117.79-72.12
Upgrade
Depreciation & Amortization
1.932.534.171.41.210.85
Upgrade
EBIT
28.5110.11-105.59-118.9-118.99-72.97
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).